ALL-43: T Lymphoblastic Leukemia/Lymphoma

Preclinical Pediatric Tumor Consortium


Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NOD/SCID intravenous, either lateral tail vein orthotopic bone marrow aspirates,peripheral blood Not Specified 0
Model Quality Control
Technique Description Passage
Fingerprinting Not specified Not specified
Publications
Title Development And Characterization Of The Novel Human Osteosarcoma Cell Line COS-33 With Sustained Activation Of The MTOR Pathway.
Authors VanCleave A, Palmer M, Fang F ... Tao J.
Publication year 2020
Journal Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway.
Patient
Sex Male
Race / Ethnicity Not specified / European
Derived Model ALL-43
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age
Diagnosis T Lymphoblastic Leukemia/Lymphoma
Type Primary
PDX Mouse ALL-43
Collection Site Bone marrow
Grade ( Classification: )
Stage Unknown ( Classification: )

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: